Markets.com Logo

CNBX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0004$
  • Previous Close
    0.0007$
  • 52 Week Change
    0.02$
  • Day Range
    -0.00$
  • 52 Week High/Low
    0.0003$ - 0.0157$
  • Dividend Per Share
    --
  • Market cap
    33 304$
  • EPS
    -0.0014
  • Beta
    0.173
  • Volume
    --

About

Connect Biopharma Holdings Limited (CNBX.US) is a global clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies for inflammatory diseases and other unmet medical needs. Their pipeline includes drug candidates targeting major global markets with significant patient populations. As a publicly traded company on the Nasdaq, Connect Biopharma is subject to SEC regulations and financial reporting requirements.
NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

NBIS Stock Outlook for 2026: What will be the future of Nebius Group?

Frances Wang|--
Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Commodity market today: Will Gold (XAU/USD) and Silver (XAG) hit new highs?

Frances Wang|--
RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

RGTI stock crashed 7% today: what’s happening with Rigetti Computing?

Frances Wang|--
Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Gold price analysis: XAU/USD price today, how high will gold go in 2026?

Frances Wang|--
Technology stock to watch in 2026: What is the new NVDA stock price target?

Technology stock to watch in 2026: What is the new NVDA stock price target?

Frances Wang|--
BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

BMNR stock up 9% today: what’s going on with BitMine Immersion Technologies?

Frances Wang|--
Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Solana (SOL) price analysis: What will SOL/USD be worth in 2026?

Frances Wang|--

Factors

Cannabics Pharmaceuticals' stock price, CNBX.US, is influenced by factors common to small-cap pharmaceutical companies, especially those in the cannabis space. Clinical Trial Results: Positive or negative data from clinical trials for Cannabics' drug candidates heavily impacts investor sentiment.

Regulatory Developments: Changes in cannabis regulations, particularly regarding medical cannabis research and availability, can significantly affect the stock.

Market Sentiment: Overall market sentiment towards the pharmaceutical and cannabis sectors influences trading volume and price.

Financial Performance: Cannabics' cash position, burn rate, and ability to secure funding affect investor confidence.

Competition: The emergence of competing drugs or therapies for Cannabics' target indications could negatively impact the stock.

News and Announcements: Company-specific announcements, like partnerships, acquisitions, or licensing agreements, influence price.

Investor Speculation: Given its small-cap nature, CNBX is susceptible to speculative trading and short-term price swings.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

A Complete Guide to Cryptos: How to Invest in Crypto as A BEGINNER In 2026?

Ghko B|--
Contracts for Difference explained: What is CFD trading, how do CFDs work?

Contracts for Difference explained: What is CFD trading, how do CFDs work?

Ghko B|--
Financial market for beginners: How financial markets work, how to invest?

Financial market for beginners: How financial markets work, how to invest?

Ghko B|--